Commentary
Ultra-low price of generic agents in China may weaken patients' drug recognition and compliance
2020 年 14 巻 2 号 p. 103-104
詳細
2020 年 14 巻 2 号 p. 103-104
Drug quantity purchase in China has reshaped the pattern of drug market with lower price of generic drugs and relatively higher price of original brand-name drugs. However, most Chinese people do not trust the safety and efficacy of the generic drugs that sold at a very low price. Ultra-low price of generic agents may weaken patients' drug recognition and compliance, and affect the implementation of drug quantity purchase policy.
